All posts by: Michael Zand

About Michael Zand

Physical therapy essential to Andrews Institute’s stem cell knee cartilage trial — 3 insights – Becker’s Orthopedic & Spine

Continue reading

2017-12-08 NEWS

Physical therapy essential to Andrews Institute’s stem cell knee cartilage trial — 3 insights
Becker’s Orthopedic & Spine
Physical therapy is playing an important role in a clinical trial being conducted at Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics & Sports Medicine, where stem cells are being used to regenerate knee cartilage. Here’s what you should know

Continue reading

2017-12-08 NEWS

5newsonline.com

DNA Is Going Digital – What Could Possibly Go Wrong?
5newsonline.com
We’ve even hosted FBI agents from the Weapons of Mass Destruction Directorate here at Colorado State University and previously at Virginia Tech for crash courses on synthetic biology and the associated cyberbiosecurity risks. A year ago, we

and more »

Continue reading

2017-12-08 NEWS

Coos Bay World

Gene therapy shows promise against blood-clotting disease
Coos Bay World
The therapy supplies the missing gene, using a virus that’s been modified so it won’t cause illness but ferries the DNA instructions to liver cells, which use them to make the clotting factor. The treatment is given through an IV. In a study published

and more »

Continue reading

2017-12-08 NEWS

Seeking Alpha

CRISPR Therapeutics: Analysis Of And Update On The B-Thalassemia Franchise
Seeking Alpha
The company recently submitted a CTA for CTX-001 (the potential treatment for the blood disorder Beta-thalassemia). It’s the first application for the CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a potentially revolutionary platform to launch a

Continue reading

2017-12-08 NEWS

Chasing leaders, Juno rides CART momentum into ASH
BioPharma Dive
For a field that not too long ago was considered science fiction, CART cell therapy has transitioned from the clinic to the market in remarkable speed. This year’s annual meeting of the American Society of Hematology (ASH), set to kick off Saturday